Johnson & Johnson (JNJ) Invested Capital (2009 - 2026)

Johnson & Johnson has reported Invested Capital for 18 years, with the latest figure at $11.7 billion in Q2 2026.

• Quarterly Invested Capital rose 1.44% year-over-year to $11.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $44.0 billion (up 22.77% YoY) and the FY2025 annual result came in at $8.5 billion, up 41.99% from the prior year.
• Invested Capital fell to $11.7 billion in Q2 2026 per JNJ's latest filing, from $17.5 billion in the prior quarter.
• Over five years, Invested Capital peaked at $18.0 billion in Q2 2023 and troughed at $3.5 billion in Q4 2023.
• A 5-year average of $8.7 billion and a median of $8.5 billion in 2025 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 318.41% in 2023, down 72.95% in 2023.
• Over 5 years, Invested Capital stood at $4.4 billion in 2022, then slipped by 21.99% to $3.5 billion in 2023, then jumped by 73.37% to $6.0 billion in 2024, then soared by 41.99% to $8.5 billion in 2025, then jumped by 37.63% to $11.7 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $11.7 billion, $17.5 billion, and $8.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.